Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness

by Jan A.C. Hontelez, Angela Y. Chang, Osondu Ogbuoji et al.
AIDS: 24 September 2016, Vol. 30, Issue 15, pp. 2341–2350

10 pp. 434 kB
http://journals.lww.com/aidsonline/Fulltext/2016/09240/Changing_HIV_treatment_eli
gibility_under_health.11.aspx
xlargethumb-00002030-201609240-00000-cv

The authors estimated the investment needs, population health gains, and cost-effectiveness of different policy options for scaling-up prevention and treatment of HIV in the 10 countries that currently comprise 80% of all people living with HIV in sub-Saharan Africa (Ethiopia, Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe). They conclude that treatment eligibility at any CD4+ cell count would be cost-effective, even under health system constraints.

(Visited 26 times, 1 visits today)
This entry was posted in General, HIV - AIDS - STI. Bookmark the permalink.